Michael E. Thase
Impact in
- Pharmacology top 0.01%
- Treatment of Major Depression
- Experimental and Cognitive Psychology top 0.02%
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Sleep and related disorders
Papers in
- Pharmacology 360
- Treatment of Major Depression 360
- Pharmacogenetics and Drug Metabolism 14
-
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes 128
- Sleep and related disorders 38
- Co-authors
- Greg J. Siegle (18 shared papers)Susan G. Kornstein (34 shared papers)Augustus John Rush (36 shared papers)John C. Markowitz (29 shared papers)Daniel N. Klein (34 shared papers)Madhukar H. Trivedi (34 shared papers)James H. Kocsis (37 shared papers)Rachel Manber (29 shared papers)
- Journals
- The Journal of Clinical Psychiatry (90 papers)Journal of Affective Disorders (33 papers)American Journal of Psychiatry (24 papers)Biological Psychiatry (22 papers)Journal of Consulting and Clinical Psychology (21 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Michael E. Thase
590 papers receiving 37.1k citations
Michael E. Thase's Hit Papers
Peers
Comparison fields: 5 of 170
- Pharmacology 15k
- Experimental and Cognitive Psychology 7.7k
- Clinical Psychology 8.6k
- Biological Psychiatry 396
- Behavioral Neuroscience 811
Countries citing papers authored by Michael E. Thase
This map shows the geographic impact of Michael E. Thase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Thase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Thase more than expected).
Fields of papers citing papers by Michael E. Thase
This network shows the impact of papers produced by Michael E. Thase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Thase. The network helps show where Michael E. Thase may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael E. Thase, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 609 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression Hit paper breakdown → | 2003 | 3221 |
| 2 | A Comparison of Nefazodone, the Cognitive Behavioral-Analysis System of Psychotherapy, and Their Combination for the Treatment of Chronic Depression Hit paper breakdown → | 2000 | 1027 |
| 3 | Frontiers of cognitive therapy Hit paper breakdown → | 1997 | 883 |
| 4 | Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design Hit paper breakdown → | 2004 | 875 |
| 5 | Increased Amygdala and Decreased Dorsolateral Prefrontal BOLD Responses in Unipolar Depression: Related and Independent Features Hit paper breakdown → | 2006 | 733 |
| 6 | 2002 | 721 | |
| 7 | 2001 | 667 | |
| 8 | Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma Hit paper breakdown → | 2003 | 648 |
| 9 | Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression Hit paper breakdown → | 2017 | 588 |
| 10 | 2000 | 572 | |
| 11 | Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study Hit paper breakdown → | 2019 | 569 |
| 12 | Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation Hit paper breakdown → | 2021 | 536 |
| 13 | Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression Hit paper breakdown → | 2019 | 479 |
| 14 | 2002 | 405 | |
| 15 | 2000 | 390 | |
| 16 | 1997 | 372 | |
| 17 | 2007 | 360 | |
| 18 | 2007 | 327 | |
| 19 | 2009 | 293 | |
| 20 | 2001 | 283 |
About Michael E. Thase
Michael E. Thase is a scholar working on Pharmacology, Experimental and Cognitive Psychology, Clinical Psychology, Psychiatry and Mental health and Pharmacology, having authored 609 papers that have together received 39.9k indexed citations. Recurring topics across this work include Treatment of Major Depression (360 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (128 papers), Psychotherapy Techniques and Applications (108 papers), Sleep and related disorders (38 papers), Bipolar Disorder and Treatment (22 papers), Substance Abuse Treatment and Outcomes (15 papers), Pharmacogenetics and Drug Metabolism (14 papers) and Psychological Treatments and Assessments (14 papers). The work is most often cited by research in Pharmacology (15k citations), Experimental and Cognitive Psychology (7.7k citations), Clinical Psychology (8.6k citations), Biological Psychiatry (396 citations) and Behavioral Neuroscience (811 citations). Michael E. Thase has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Greg J. Siegle, Susan G. Kornstein, Augustus John Rush, John C. Markowitz, Daniel N. Klein, Madhukar H. Trivedi, James H. Kocsis, Rachel Manber, Martin B. Keller and Stuart R. Steinhauer. Their work appears in journals such as The Journal of Clinical Psychiatry, Journal of Affective Disorders, American Journal of Psychiatry, Biological Psychiatry and Journal of Consulting and Clinical Psychology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.